A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Huvudupphovsman: | Shehab, Habibul Mohsin |
---|---|
Övriga upphovsmän: | Yasmin, Hasina |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
Brac University
2024
|
Ämnen: | |
Länkar: | http://hdl.handle.net/10361/22683 |
Liknande verk
-
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
av: Tabassum, Nadira
Publicerad: (2024) -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
av: Mahee, Sadique Abdal
Publicerad: (2024) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
av: Alim, Abdul
Publicerad: (2023) -
Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
av: Karmaker, Swastika
Publicerad: (2024) -
A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
av: Jahan, Nusrat
Publicerad: (2023)